Anna Bellmunt, PhD, joined LSP as an Analyst in 2020. She is part of the LSP investment team focused on unlisted equities and is involved in all stages of the investment process. Within LSP, she is responsible for the initial deal flow screening, selection of the most interesting and innovative investment opportunities, and in-depth scientific and clinical due diligence on investment opportunities for assessing their future potential.
Prior to joining LSP, Anna was an Innovation Manager at the Knowledge and Technology Transfer Office at Hospital Clínic de Barcelona and its Research Institute IDIBAPS where she was involved in the management of innovative healthcare projects. Her primary role was to advise entrepreneurs on intellectual property protection strategies, negotiate licensing contracts with the Pharmaceutical Industry and facilitate the creation of spin-off companies.
Previously, Anna was a researcher in the Growth Control and Cancer Metastasis group at the IRB Barcelona. Her main research focused on mechanisms of metastasis, specifically in breast cancer bone metastasis. Her results were published in numerous leading scientific journals, including Nature Cell Biology.
Anna was awarded a PhD in Biomedicine from the University of Barcelona (UB), a Master’s degree in Biomedical Research from Pompeu Fabra University (UPF) and Anna holds two Bachelor’s degrees; in Chemistry and Biochemistry, by the University of Barcelona (UB). She combined her studies with scientific research training in several research groups in Paris and Barcelona. Anna lives in Munich.
To contact Anna directly, email firstname.lastname@example.org or call +49 (0) 89 120 850 90.